Skip to content

Burn Out Among Medical Family Doctors

Study of the Prevalence, Risk Factors and Protective Factors of Burnout Among General Practitioners in France

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04242862
Acronym
BOUM
Enrollment
1536
Registered
2020-01-27
Start date
2016-11-01
Completion date
2022-06-01
Last updated
2020-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Burnout, Professional, Depressive Disorder, Mental Health Wellness 1, Occupational Stress

Keywords

General Practitioners, Private Practice, Models, Organizational, Behavior and Behavior Mechanisms, Test Anxiety Scale, Surveys and Questionnaires, Cross-Sectional Studies

Brief summary

The main objective of this study is to assess the burnout prevalence among French general practitioners in private practice. As secondary outcomes, this study aim to measure the impact of sociodemographic variables, organizational practice models and workload. the investigators also intend to characterize the prevalence of depression, anxiety, fatigue and stress, drugs and alcohol consumption, use of psychotropic medication, and preferred strategies to cope with their symptoms.

Detailed description

The BOUM protocol is designed to provide a better understanding of the current burnout prevalence among French general practitioners, as well as its risk and protective factors. In order to fulfil those objectives, the methodologist estimated a 1536 individuals sample size, using an expected prevalence of severe burnout ranged between 10% and 20% (from the the EGPRN study - Soler, J.K., et al., Burnout in European family doctors: the EGPRN study. Family Practice, 2008. 25(4): p. 245-265), thus allowing the investigators to retrieve results with a 95% confidence level and a 2% error margin. All analyses will be performed in a bilateral formulation for a 5% alpha error under the Stata® software (version 13, StataCorp, College Station, US). A difference will be considered statistically significant for p\<0.05. The population will be described as frequency and percentage for the categorical variables, and as mean ± standard deviation or median \[interquartile range\] for the quantitative variables, according to their statistical distribution (normality studied by the Shapiro-Wilk test). Confidence intervals for population prevalence will be characterised with a binomial test. Comparisons between groups of burnout will be performed using Chi2 or Fisher's exact test for the categorical variables (followed by a Marascuillo post-hoc tests if needed), and by an ANOVA or Kruskal-Wallis test if normality and homoscedasticity not respected (Bartlett test) for the quantitative variables (followed by Tukey-Kramer or Dunn tests when necessary). Finally, considering the variables clinically relevant and those with a pertinent univariate analysis results, a multivariate analyse of ordinal polynomial regression type will be proposed; its results will be expressed as relative risk with 95% confidence intervals and presented as a Forest-plot.

Interventions

None listed

Sponsors

UFR Médecine & Pharmacie - Université Clermont Auvergne
CollaboratorUNKNOWN
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* General practitioners working in France

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Burnout in French General PractitionersDay 1To evaluate the burnout prevalence in French General Practitioners, using the Maslach Burn-Out Inventory questionnaire

Secondary

MeasureTime frameDescription
DepressionDay 1Hospital Anxiety and Depression scalewill be assessed and related to with demographic information and occupational characteristics
StressDay 1Visual analog scale will be assessed and related to with demographic information and occupational characteristics
FatigueDay 1Visual analog scale will be assessed and related to with demographic information and occupational characteristics
AnxietyDay 1Hospital Anxiety and Depression scale will be assessed and related to with demographic information and occupational characteristics
Psychiatric history and clinical approachesDay 1Participants will be asked about any previous psychiatric diagnosis, suicidal attempt, use of any psychotropic medication and usual stress management approaches.
Addictive behaviorsDay 1Alcohol, tobacco and other psychotropic drugs consumption, through questionnaires assessment
sleep disturbanceDay 1Validated questionnaire will be assessed and related to with demographic information and occupational characteristics

Countries

France

Contacts

Primary ContactLise Laclautre
promo_interne_drci@chu-clermontferrand.fr0473754963

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026